PhaseBio Pharmaceuticals Inc
DelistedCIK 1169245fmd_0JBJM9WPVJD9FVMG6JKJGKG7ZVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Jun 30, 2022, 20 periods
Latest annual · FY2021
Millions- Total revenues
- 11
- Operating income
- (107)
- Net income
- (131)
- Free cash flow
- (50)
Latest quarter · Q2 FY2022
Millions- Total revenues
- 0
- Operating income
- (25)
- Net income
- (17)
- Free cash flow
- (10)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +153.1%
PhaseBio Pharmaceuticals Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $10.8 million | $320,000 | +3,284.7% | 10-K 2022-03-24 · proof |
| Operating income | -$107.4 million | -$84.9 million | 10-K 2022-03-24 · proof | |
| Net income | -$131.1 million | -$98.6 million | 10-K 2022-03-24 · proof | |
| Cash from operating activities | -$47.4 million | -$60 million | 10-K 2022-03-24 · proof | |
| Free cash flow | -$50.1 million | -$61.3 million | 10-K 2022-03-24 · proof | |
| Total assets | $60.5 million | $50.4 million | +20.2% | 10-K 2022-03-24 · proof |
| Total liabilities | $153.6 million | $75.6 million | +103.3% | 10-K 2022-03-24 · proof |
| Cash and cash equivalents | $41.8 million | $28.1 million | +48.6% | 10-K 2022-03-24 · proof |
| Total debt | $6.8 million | $12.1 million | -44.2% | 10-K 2022-03-24 · proof |
- What was PhaseBio Pharmaceuticals Inc's revenue in fiscal 2021?
- PhaseBio Pharmaceuticals Inc reported revenue of $10.8 million for fiscal 2021 (the year ended Dec 31, 2021), against $320,000 the year before (+3,284.7%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was PhaseBio Pharmaceuticals Inc's operating income in fiscal 2021?
- PhaseBio Pharmaceuticals Inc reported operating income of -$107.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$84.9 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was PhaseBio Pharmaceuticals Inc's net income in fiscal 2021?
- PhaseBio Pharmaceuticals Inc reported net income of -$131.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$98.6 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was PhaseBio Pharmaceuticals Inc's cash from operating activities in fiscal 2021?
- PhaseBio Pharmaceuticals Inc reported cash from operating activities of -$47.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$60 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was PhaseBio Pharmaceuticals Inc's free cash flow in fiscal 2021?
- PhaseBio Pharmaceuticals Inc reported free cash flow of -$50.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$61.3 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are PhaseBio Pharmaceuticals Inc's total assets?
- As of Dec 31, 2021, PhaseBio Pharmaceuticals Inc reported total assets of $60.5 million, against $50.4 million a year earlier (+20.2%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are PhaseBio Pharmaceuticals Inc's total liabilities?
- As of Dec 31, 2021, PhaseBio Pharmaceuticals Inc reported total liabilities of $153.6 million, against $75.6 million a year earlier (+103.3%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are PhaseBio Pharmaceuticals Inc's cash and cash equivalents?
- As of Dec 31, 2021, PhaseBio Pharmaceuticals Inc reported cash and cash equivalents of $41.8 million, against $28.1 million a year earlier (+48.6%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What is PhaseBio Pharmaceuticals Inc's total debt?
- As of Dec 31, 2021, PhaseBio Pharmaceuticals Inc reported total debt of $6.8 million, against $12.1 million a year earlier (-44.2%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1169245&period_type=annual&limit=5"Information only, not investment advice.